Skip to content

Traumatization and PTSD in people with Mild Intellectual Disabilities or Borderline Intellectual Functioning (MID-BIF) and*severe*behavioural*problems: screening, assessment and treatment.**

Traumatization and PTSD in people with Mild Intellectual Disabilities or Borderline Intellectual Functioning (MID-BIF) and*severe*behavioural*problems: screening, assessment and treatment.** - Traumatization and PTSD in people with MID-BIF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50816
Enrollment
100
Registered
2021-04-14
Start date
2022-12-06
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatische Stressstoornis (PTSS) PTSD trauma

Interventions

None listed

Sponsors

's Heeren Loo, afdeling WOK
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Study #1 and Study #2:** The participants are 18 years or older and have a MID-BIF (IQ between 50 and 85 and deficits in adaptive skills) and sufficient Dutch language skills. All participants receive residential or outpatient care from 's Heeren Loo. Participants have a VG6 or VG7 care profile, granted by the Dutch Healthcare Authority (Nederlandse*Zorgautoriteit:*NZa). Study #3:** Participants of Study #3 are 18 years*or*older*and*have a MID-BIF (IQ between 50 and 85) and SBP and PTSD. The SBP are explicitly described in their file, but this is also apparent from daily reports and incident reports. They stay in a residential setting at 's Heeren Loo. The participants have both a VG7 care profile and an allowance for extreme care, granted by the Dutch Healthcare Authority (Nederlandse*Zorgautoriteit:*NZa).** Study #4:* Eight clients and eight EMDR-therapists who are involved in Study #3.**

Exclusion criteria

Exclusion criteria: Study #1 and Study #2:* Suicidality, drug use and seriously sedating medication (e.g. anxiety inhibitors) are used as exclusive criteria.* Study #3 and #4:* Suicidality, drug use and seriously sedating medication (e.g. anxiety inhibitors) are used as exclusive criteria. An EMDR supervisor*(dr. Liesbeth Mevissen), specialized in the field of people with MID-BIF, will be involved in the inclusion of the clients. In addition, advice can be sought from the psychologist and physician involved*with regard to*the exclusion criteria. Further, it is important that the support teams of the participants are*more or less stable, and the teams should be open to research.*

Design outcomes

Primary

MeasureTime frame
In Study #1 and Study #2 the main study parameter is number of PTSD symptoms, in Study #3 the main study parameter is number of loss of PTSD symptoms. The main study parameter of Study #4 is the expectation and experiences of therapists and clients of an intensive EMDR therapy with rotating therapists.

Secondary

MeasureTime frame
In Study #1, Study #2 and Study #4*there are no secondary study parameters.*Secondary outcome study parameters of Study #3 are*behavioural*goals,*severity of SBP,*and*frequency and intrusiveness of applied coercive measures.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)